{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of CMV pp65 mRNA-Loaded Dendritic Cell Vaccination"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "randomised controlled trial involved four CMV-seronegative healthy volunteers and three allogeneic HSCT recipients"
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at Antwerp University Hospital, this randomised controlled trial involved four CMV-seronegative healthy volunteers and three allogeneic HSCT recipients"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants received four weekly intradermal DC vaccines, prepared from a single leukapheresis"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the safety, feasibility, and immunogenicity of CMV pp65 mRNA-loaded autologous monocyte-derived dendritic cells (DC) as a vaccine"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the induction of CMV-specific T-cell responses, evaluated one month post-vaccination"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "randomisation and allocation concealment methods were not detailed"
      },
      "Blinding": {
        "score": 0,
        "evidence": "The study was not blinded"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "The trial did not specify the number of participants randomised to each group"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "The trial did not specify the number of participants randomised to each group or the analysis approach"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "In healthy volunteers, three of four exhibited de novo CMV-specific T-cell responses without serious adverse events"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events included transient local redness and mild swelling at the injection site, with no serious events in healthy subjects"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration and funding information were not provided"
      },
      "Funding": {
        "score": 0,
        "evidence": "Trial registration and funding information were not provided"
      }
    },
    "total_score": 12,
    "max_score": 25
  },
  "model": "gpt-4o"
}